1051971-75-5 Usage
Uses
Used in Catalysis Applications:
Di(4-pyridylethinyl) zinc bis[3-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]phenyl]porphyrin-ethinyl dimer is utilized as a catalytic agent for its ability to facilitate various chemical reactions. The presence of the zinc atom and the complex organic framework allows for efficient interaction with reactant molecules, enhancing the rate of reactions and improving overall catalytic performance.
Used in Photodynamic Therapy:
In the medical field, Di(4-pyridylethinyl) zinc bis[3-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]phenyl]porphyrin-ethinyl dimer serves as a photosensitizer in photodynamic therapy, where it can absorb light and generate reactive oxygen species, which are effective in eliminating cancerous cells or harmful microorganisms. The porphyrin ring's light-absorbing properties, combined with the ethinyl groups and the zinc coordination, make it a promising candidate for targeted treatments.
Used in Nanotechnology:
Di(4-pyridylethinyl) zinc bis[3-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]phenyl]porphyrin-ethinyl dimer is employed in nanotechnology for its potential in the development of nanoscale devices and materials. Di(4-pyridylethinyl) zinc bis[3-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]phenyl]porphyrin-ethinyl dimer's complex structure and metal-organic interactions can be harnessed to create novel nanomaterials with unique electronic, optical, or magnetic properties, useful in various high-tech applications.
Used in Chemical Sensors:
Di(4-pyridylethinyl) zinc bis[3-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]phenyl]porphyrin-ethinyl dimer can also be used as a sensing element in chemical sensors due to its ability to selectively interact with specific target molecules. The presence of the zinc atom and the organic groups can provide a high degree of selectivity and sensitivity, making it suitable for detecting trace amounts of analytes in environmental or industrial settings.
Used in Dye-Sensitized Solar Cells:
In the renewable energy sector, Di(4-pyridylethinyl) zinc bis[3-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]phenyl]porphyrin-ethinyl dimer can be applied as a dye in dye-sensitized solar cells. Di(4-pyridylethinyl) zinc bis[3-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]phenyl]porphyrin-ethinyl dimer's light-absorbing characteristics and the ability to transfer electrons efficiently make it a candidate for improving the performance and efficiency of solar energy conversion devices.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, this complex chemical may be explored for its potential in drug design and development. The unique structure and properties of the compound could be leveraged to create new drugs with specific therapeutic effects or to improve the delivery and efficacy of existing medications.
Each application is based on the compound's distinct chemical and physical properties, which are derived from its intricate molecular structure and the synergistic effects of its metal and organic components.
Check Digit Verification of cas no
The CAS Registry Mumber 1051971-75-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,1,9,7 and 1 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1051971-75:
(9*1)+(8*0)+(7*5)+(6*1)+(5*9)+(4*7)+(3*1)+(2*7)+(1*5)=145
145 % 10 = 5
So 1051971-75-5 is a valid CAS Registry Number.
1051971-75-5Relevant academic research and scientific papers
Synthesis of hydrophilic conjugated porphyrin dimers for one-photon and two-photon photodynamic therapy at NIR wavelengths
Balaz, Milan,Collins, Hazel A.,Dahlstedt, Emma,Anderson, Harry L.
, p. 874 - 888 (2009/05/30)
We report the synthesis of a series of hydrophilic butadiyne-linked conjugated zinc porphyrin dimers (1-7), designed as photodynamic therapy (PDT) agents. These porphyrin dimers exhibit exceptionally high two-photon absorption cross sections (δmax≈ 8,000-17,000 GM) and red-shifted linear absorption spectra (λmax≈ 700-800 nm) making them ideal candidates for one-photon and two-photon excited photodynamic therapy. Four polar triethyleneglycol substituents are positioned along the sides of each dimer, but, on their own, these TEG chains do not confer sufficient solubility in aqueous physiological media for reproducible delivery into live cells. Charged cationic (methylpyridinium and trimethylammonium) and anionic (sulfonate and carboxylate) substituents have been appended to the meso-positions of porphyrin dimers using three synthetic strategies: 1) Suzuki coupling, 2) Sonogashira coupling, and 3) nucleophilic Senge arylation. Approaches 1 and 3 both allow attachment of aromatic substituents directly to the meso-positions of porphyrins. Approach 2 provides a route to hydrophilic porphyrin dimers with an ethyne link between the porphyrin and the polar aromatic substituent. The palladium-catalysed approaches 1 and 2 allow the synthesis of a broader range of meso-capped porphyrins, as many aryl halides are available. However the synthesis of the intermediate required for these routes necessitates a statistical reaction step, which decreases the overall yield. On the other hand, Senge-arylation provides highly regioselective nucleophilic aromatic substitution, and offers higher overall yield than the other routes. All these charged dimers exhibit good solubility in polar solvents (e.g. methanol) and aqueous solvent mixtures (aqueous DMSO or DMF).
PORPHYRIN COMPOUNDS
-
Page/Page column 25; 27-28, (2008/12/04)
The present invention relates to porphyrin compounds of formula (I), to processes for preparing said compounds, to pharmaceutical compositions comprising said compounds and their use in photodynamic therapy. The porphyrin compounds exhibit high two photon absorption cross section values, are soluble and are readily absorbed by cells making them suitable for use in two photon photodynamic therapy.
